AHL Partners’s DexCom DXCM Stock Holding History

AHL Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-23,760	Closed	-$521K	–	1069
2016 Q3	$521K	Buy	+23,760	New	+$529K	0.02%	826

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

AHL Partners's DXCM Position: Q4 2016 in Review

AHL Partners sold out of DexCom (DXCM) in Q4 2016, closing a stake of 23,760 shares — an estimated $521K sold.

AHL Partners first reported a position in DXCM in Q3 2016 and held it in 1 quarter. The position peaked at $521K in Q3 2016. 316 funds tracked by Wall St. Rank hold DXCM as of Q4 2016.

AHL Partners reported no remaining DexCom position as of Q4 2016 after selling out during the quarter.
AHL Partners sold 23,760 DexCom shares in Q4 2016, an estimated $521K.
AHL Partners first reported a position in DexCom in Q3 2016 and held it in 1 quarter.
AHL Partners's DexCom position peaked at $521K in Q3 2016.
316 funds tracked by Wall St. Rank held DexCom as of Q4 2016.

Based on AHL Partners's 13F filing for Q4 2016, filed 14 Feb 2017.